A judge has expressed concerns after hearing that up to 20,000 group members in three pelvic mesh class actions have yet to receive payment from $405 million in settlements approved in March last year.
A class action over deaths allegedly caused by negligent care at a NSW aged care facility during COVID-19 has settled.Â
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
A judge has ordered Victoria’s Peninsula Health to fork over $316,260 in penalties for failing to pay overtime to a junior doctor leading a class action, saying the hospital operator had a âhighly irresponsible attitudeâ.
A ninth class action has been filed on behalf of junior doctors in Victoria who were allegedly underpaid for shift work, after two landmark wins in the Gordon Legal-led underpayments class actions.
Cipla is opposing the extension of Novo Nordiskâs patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.
Medibank is seeking to shield from a shareholder class action an “irrelevant” post-incident report by Deloitte into its massive October 2022 data breach.
AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta.Â
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.